{
    "id": "05e38764-a608-4b0d-9574-37435d998ded",
    "indications": {
        "text": "gabapentin capsules indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 15mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "100 mg capsules : opaque white cap opaque white body imprinted 's617/100 mg ' cap edible blue ink strides logo body edible green ink . filled white white powder ; available : bottles 100 : ndc 23155-866-01 bottles 500 : ndc 23155-866-05 bottles 1000 : ndc 23155-866-10 300 mg capsules : opaque yellow cap opaque yellow body imprinted 's618/300 mg ' cap edible blue ink strides logo body edible green ink . filled white white powder ; available : bottles 100 : ndc 23155-867-01 bottles 500 : ndc 23155-867-05 bottles 1000 : ndc 23155-867-10 400 mg capsules : opaque orange cap opaque orange body imprinted 's619/400 mg ' cap edible blue ink strides logo body edible green ink . filled white white powder ; available : bottles 100 : ndc 23155-868-01 bottles 500 : ndc 23155-868-05 bottles 1000 : ndc 23155-868-10 store gabapentin capsules 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . dispense contents tight , light-resistant container defined usp child-resistant closure ; required . keep container tightly closed keep medication reach children .",
    "adverseReactions": "gabapentin capsules contraindicated patients demonstrated hypersensitivity ingredients .",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        }
    ],
    "organization": "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.",
    "name": "GABAPENTIN",
    "effectiveTime": "20250519",
    "indications_original": "Gabapentin capsules are indicated for:\n                  \n                     Management      of postherpetic neuralgia in adults\n                     Adjunctive therapy in      the treatment of partial onset seizures, with and without secondary      generalization, in adults and pediatric patients 3 years and older with      epilepsy",
    "contraindications_original": "Postherpetic      Neuralgia (2.1) Dose      can be titrated up as needed to a dose of 1800 mg/day Day      1: Single 300 mg dose Day      2: 600 mg/day (i.e., 300 mg two times a day) Day      3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy      with Partial Onset Seizures (2.2) Patients      12 years of age and older: starting dose is 300 mg three times daily; may      be titrated up to 600 mg three times daily Patients      3 to 11 years of age: starting dose range is 10 to 15mg/kg/day, given in      three divided doses; recommended dose in patients 3 to 4 years of age is      40 mg/kg/day, given in three divided doses; the recommended dose in      patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three      divided doses. The recommended dose is reached by upward titration over a      period of approximately 3 days Dose      should be adjusted in patients with reduced renal function (2.3, 2.4)",
    "warningsAndPrecautions_original": "100 mg capsules:\n                  Opaque white cap and opaque white body imprinted with 'S617/100 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder; available in:\n                  Bottles of 100: NDC 23155-866-01\n                  Bottles of 500: NDC 23155-866-05\n                  Bottles of 1000: NDC 23155-866-10\n                  300 mg capsules:\n                  Opaque yellow cap and opaque yellow body imprinted with 'S618/300 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder; available in:\n                  Bottles of 100: NDC 23155-867-01\n                  Bottles of 500: NDC 23155-867-05\n                  Bottles of 1000: NDC 23155-867-10\n                  400 mg capsules:\n                  Opaque orange cap and opaque orange body imprinted with 'S619/400 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder; available in:\n                  Bottles of 100: NDC 23155-868-01\n                  Bottles of 500: NDC 23155-868-05\n                  Bottles of 1000: NDC 23155-868-10\n                  Store Gabapentin Capsules at 25\u00b0C (77\u00b0F); excursions permitted between 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [See USP Controlled Room Temperature].\n                  Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure; as required.\n                  KEEP CONTAINER TIGHTLY CLOSED\n                  \n                     KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.",
    "adverseReactions_original": "Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.",
    "drug": [
        {
            "name": "GABAPENTIN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_42797"
        }
    ]
}